Delivery Order SPE2DR25D1104-SPE2DR26FK073
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,490 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating AmerisourceBergen competed against other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $9,122.50 with completion scheduled for October 7, 2025. This firm fixed-price delivery order, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $36,490 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gel-One 30 mg/3 mL syringes under a firm fixed-price contract. The order is expected to be completed by October 17, 2025, with performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. This is a non-set-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal medical supply...
- The Defense Logistics Agency awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price contract, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The contract was...
- The Defense Logistics Agency awarded a $14,596 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gel-One 30 mg/3 mL syringes. The contract, which is competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.60 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL) on August 29, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, non-set-aside delivery order issued without competitive restrictions, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The product will be performed at the contractor's Conshohocken,...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK073Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,691.00 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 ml syringes on October 20, 2025. This is a firm fixed price, non-set-aside contract with performance expected to be completed by November 10, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. As a leading pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen leverages this prime contract vehicle to supply an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 10/20/25 |